Showing results (201-210 of 260) with videos related to
Sort By:
Pageof 26
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2025
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trialCas Stefaan Dejonckheere, Younèss Nour, Jörg Sahlmann, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2023
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trialsIlinca Popp, Rianne D W Vaes, Lotte Wieten, et al.Plos One|November 1, 2023
Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA-A study protocolAlexander Runkel, David Braig, Balazs Bogner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trialHans Theodor Eich, Volker Diehl, Helen Görgen, et al.Cancers|November 19, 2020
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair AnalysisNina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, et al.Frontiers in Oncology|May 27, 2021
Combining <sup>68</sup>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.BMC Cancer|May 1, 2020
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapyAnn-Kathrin Oehus, Stephanie G C Kroeze, Nina-Sophie Schmidt-Hegemann, et al.The Lancet. Oncology|March 16, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trialUrsula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, et al.Cancer Medicine|March 25, 2018
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)Stephanie E Combs, Maximilian Niyazi, Sebastian Adeberg, et al.Clinical and Translational Radiation Oncology|August 18, 2025
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort studyCas S Dejonckheere, Thomas Zeyen, Cathrina Duffy, et al.Pageof 26